Targeted pharmaceutical nanocarriers for cancer therapy and imaging
Top Cited Papers
- 1 June 2007
- journal article
- review article
- Published by Springer Nature in The AAPS Journal
- Vol. 9 (2), E128-E147
- https://doi.org/10.1208/aapsj0902015
Abstract
The use of various pharmaceutical nanocarriers has become one of the most important areas of nanomedicine. Ideally, such carriers should be specifically delivered (targeted) to the pathological area...Keywords
This publication has 221 references indexed in Scilit:
- Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancerThe Prostate, 2005
- TAT-mediated protein transduction and targeted delivery of fusion proteins into mitochondria of breast cancer cellsDNA Repair, 2005
- Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat modelThe Prostate, 2005
- Cytosolic delivery of macromolecules: II. Mechanistic studies with pH-sensitive morpholine lipidsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2003
- Targeting of the photocytotoxic compound AlPcS4 to hela cells by transferrin conjugated peg‐liposomesInternational Journal of Cancer, 2002
- VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell deathThe Journal of Gene Medicine, 2001
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migrationNature Medicine, 1998
- Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990